• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, August 24, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Probiotics: Novel biosynthetic tool to develop metallic nanoparticles

Bioengineer by Bioengineer
July 20, 2017
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Probiotics, being live microbes, exert numerous beneficial health effects on the host cells. Such probiotics are commercially available as dietary supplements, foods, pharmaceutical formulations. Yakult, Activia yogurt, DanActive fermented milk provide health benefits like boosting up the immune system, treating digestive problems, mental illness, neurological disorders, cancer, etc. However, the use of probiotic bacteria to develop metallic nanoparticles (MNPs) constitutes novel research nowadays. Research inputs and patent reports according to an article published in the journal Recent Patents on Drug Delivery and Formulation highlight their potential in the field of cosmetics, pharmaceuticals, medicine and biotechnology as well.

Prof. Kamla Pathak, the corresponding author said: "Our review findings reinstate the potential of probiotic bacteria to produce MNPs. Patents (US, EP and WIPO patents) during 2009-2016 reaffirm the research and inspire the scientific community worldwide for future exploration. This is the first review article in this aspect that systematically tracks the intellectual aspects of applications and synthesis of MNPs by probiotic bacteria. Prof. Pathak said, "Our study details the interventions on which research on MNPs is on. Gold, silver, magnetic, selenium, iron oxide, magnetic-optical iron oxide-gold core-shell, magnesium oxide, copper oxide, aluminum oxide, titanium dioxide, zinc oxide nanoparticles have applications ranging from their usage in analytical methodologies to treat and diagnose diseases. Specifically, gold NPs are suggested for drug delivery and treating lymphocytic leukemia; silver and copper NPs for antimicrobial activity and zinc oxide NPs as anti-corrosive, antifungal and as an additive in food products such as breakfast cereals. These NPs need to be explored more as no patent till date was found on them based on their biosynthesis, according to the author's report.

###

For more information about the article, please visit http://www.eurekaselect.com/node/150848/article/probiotics-as-a-tool-to-biosynthesize-metallic-nanoparticles-research-reports-and-patents-survey

Reference: Akhtar N et al (2017). Probiotics as a Tool to Biosynthesize Metallic Nanoparticles: Research Reports and Patents Survey, Recent Patents on Drug Delivery & Formulation, DOI: 10.2174/1872211311666170313124335

Media Contact

Faizan ul Haq
[email protected]
@BenthamScienceP

http://benthamscience.com/

http://dx.doi.org/10.2174/1872211311666170313124335

Share12Tweet8Share2ShareShareShare2

Related Posts

Study reveals surge in type 2 diabetes among people under 20

August 24, 2026

Blocking glucosylceramide production kills cancer cells via lysosomal dysfunction, not ceramide buildup

August 23, 2026

ZCCHC4 boosts replication-dependent histone mRNA translation by interacting with eIF3

August 23, 2026

Tirzepatide Versus GLP-1 Agonists for Stroke Risk in Atrial Fibrillation and Diabetes

August 22, 2026
Please login to join discussion

POPULAR NEWS

  • Cochrane Map Reveals Major Evidence Gaps in Dengue Prevention Research

    Cochrane Map Reveals Major Evidence Gaps in Dengue Prevention Research

    29 shares
    Share 12 Tweet 7
  • Study reveals surge in type 2 diabetes among people under 20

    29 shares
    Share 12 Tweet 7
  • KAIST discovers pathway to faster-charging, longer-lasting electric vehicle batteries

    29 shares
    Share 12 Tweet 7
  • Blocking glucosylceramide production kills cancer cells via lysosomal dysfunction, not ceramide buildup

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cochrane Map Reveals Major Evidence Gaps in Dengue Prevention Research

Study reveals surge in type 2 diabetes among people under 20

KAIST discovers pathway to faster-charging, longer-lasting electric vehicle batteries

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.